It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. (TSX-V.BTI, OTC:BIOAF, Forum) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain. And while much has been accomplished by this cutting-edge biotech in 2020, much more exciting news is expected in the pipeline for 2021.
In a relatively short period of time, the Company has generated real shareholder value by developing and commercializing its proprietary brain delivery technology – XB3 – to make life-saving drugs brain-penetrant and deliver those drugs at a therapeutically relevant dose.
In this must-hear end-of-year vodcast, Stockhouse Media’s Dave Jackson was joined by CEO Dr. Deborah Rathjen to talk more about the genesis of the amazing xB3 platform, its long-term investment potential, and all things Bioasis moving forward into 2021.
PODCAST: Stockhouse CEO Interview Series with the CSE's Richard Carleton
PODCAST: Stockhouse Hosts Expert Panel on Battery Metals
Podcast #70 ProMIS Neurosciences Inc. CEO Dr. Elliot Goldstein
Podcast #71 Grown Rogue CEO Obie Strickler
FinCanna Update Call
Stockhouse Media Interview with Colin Fisher
Rick Rule Talks Investment Opportunities: Good Value and Bad Ideas
Podcast #69 Nighthawk Gold Corp
Frank Holmes Talks Markets
Podcast #68 Granada Gold Mine Inc.
Blockchain 101 Podcast - Eps 6 - Peter McCormack
Podcast #67 Bluebird Battery Metals
Podcast #66 Blockstrain Technology Corp
Blockchain 101 Podcast - Eps 5 - Chase Cedar
Podcast #65 Osisko Gold Royalties (2)
Podcast #64 MedMen Enterprises
Blockchain 101 Podcast - Eps 4 - Jonathan Hamel
Podcast #58 Anaconda Mining Inc
Blockchain 101 Podcast - Eps 3 - Samson Mow
Blockchain 101 Podcast - Eps 2 - Andrew Kiguel
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast